Modulation of Phosphoprotein Activity by Phosphorylation Targeting Chimeras (PhosTACs)

Chen, Po-Han, Hu, Zhenyi, An, Elvira, Okeke, Ifunanya, Zheng, Sijin, Luo, Xuanmeng, Gong, Angela, Jaime-Figueroa, Saul +1 more·2021·ACS Chemical Biology
DOI 10.1021/acschembio.1c00693

Cited by (130)

Items 101–130 of 130

  1. TogoPhosTAC as a delivery-ready platform for targeted protein dephosphorylation
    Yu-Yu Chen, Dong-Ting Ke, Yen‐Chun Lee, Hong‐Ru Chen, Hsiang-Ying Lin, Chen-Lin Yeh, Yu-Ching Ko, Meng‐Han Tu, Chien‐Hung Yu, Zhenyi Hu et al. · 2026 · Nature Communications
  2. Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting
    Madihah Hussain, Gonzalo S. Tejeda, George S. Baillie · 2025 · FEBS Journal
  3. Covalent Bifunctional Molecules (CBMs): Achievements and Challenges
    Yuting Xin, Fangsu Chen, Qidong You, Lei Wang, Qiuyue Zhang · 2025 · Medicinal Research Reviews
  4. Targeted Protein Degradation – The Story So Far
    Daniel H. O’Donovan, Laura Martina Luh, Philipp M. Cromm · 2022
  5. Rewiring the fusion oncoprotein EWS/FLI1 in Ewing sarcoma with bivalent small molecules
    Michael J. Bond, Ryan P. Golden, Giulia DiGiovanni, Briana Howard, Roman C. Sarott, Basel A. Karim, Sai P. Gourisankar, Gabriela Alexe, Kenneth N. Ross, Nathanael S. Gray et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  6. An epigenetic bifunctional that toggles between transactivation and repression
    Ananthan Sadagopan, Maximilian Carson, Eriks J. Zamurs, Shanivi Srikonda, Cary N. Weiss, Michael J. Bond, Anurag Sodhi, Katherine A. Donovan, Julia K Ryan, Eric S. Fischer et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  7. The Future of Heterobifunctional Compounds: PROTACs and Beyond
    George M. Burslem · 2022 · Wiley eBooks
  8. Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
    Ophir Shalem, Yevgeniy V. Serebrenik, D.R. Mani, Timothé Maujean, George M. Burslem · 2023 · Research Square
  9. Catalytic Protein Inhibitors
    Thomas J. Kodadek · 2023 · Angewandte Chemie
  10. TogoPhosTAC: A Ready-To-Go and Adaptable Targeted Protein Dephosphorylation System
    Po‐Han Chen, Yu-Yu Chen, Dong-Ting Ke, Yen‐Chun Lee, Chen-Lin Yeh, Yu-Ching Ko, Meng‐Han Tu, Chien‐Hung Yu, Zhenyi Hu · 2025 · Research Square
  11. The next frontier in drug discovery: Unveiling the pharmacological potential of proximity inducers
    Natalie Holmberg‐Douglas, Katherine N. Keenan, Felix González-López de Turiso, Eugene P. Chekler, Veerabahu Shanmugasundaram, Jennifer R. Riggs, Christoph W. Zapf · 2025 · Elsevier eBooks
  12. Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy
    Tian Qiu, Yeuan Ting Lee, Brendan G. Dwyer, Yi Jer Tan, Ting Chen, Bryan A. Romero, Yanlan Wang, Jiehui Deng, Tinghu Zhang, Gerald R. Crabtree et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Sheddase Targeting Chimeras (SHEDTACs) catalyze membrane target proteolysis
    Brett M. Garabedian · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  14. Recent advance in the targeted protein degradation technology for overcoming acute leukemia
    Xin Jin, Zhonghua Shi, Zhuo Liang, Jia Chen, Chenxi Wang, Yongxin Lou, Xiaoran Cao, Lei Zhu, Yihuan Zhao, Changkuo Zhao et al. · 2026 · European Journal of Medicinal Chemistry Reports
  15. CD19-CAR-T phenotyping during Prodigy manufacturing uncovers critical T cell transition
    Florian Schinle, Florian Schinle, Isa-Maria Klink, Felix Schäfer, Sylvia Klein, K. Lutz, Maximilian Feige, Kathrin Wolsing, Simon Fink, Tamam Bakchoul et al. · 2026 · Research Square
  16. Dual inhibition of PP2A and WEE1 induces apoptosis and mitotic catastrophe in cancer cells
    Al‐Hassan M. Mustafa, Alexandra Nguyen, Sophie Kreissig, Yanira Zeyn, Yesim Melisa Gürbüzoglu, Stefan Stoldt, Matthias Bros, Markus Philipp Radsak, Walburgis Brenner, Linping Chen-Wichmann et al. · 2026 · Biomedicine & Pharmacotherapy
  17. High‐throughput Phosphoproteomics Reveals the Role of Phosphorylation in Pluripotency and Phase Separation
    Yanna Tang, Haiming Huang, Ting Wu, Jialin Du, Lu Pang, Hongyun Yang, Haixia Li, Jinhuan Wei, Qian Ma · 2026 · PROTEOMICS
  18. Post-translational modifications of influenza virus proteins
    Menghuan Cui, Shuyi Wang, Xiao Fei, Guijie Guo · 2026 · Genes & Diseases
  19. The NanoBridge system for targeted post-translational modification of challenging proteins
    Fangfang Shen, Olga D. Merino-Chavez, Sheng‐Yao Dai, Sebastian A Alfonso, Laura M. K. Dassama · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Small-molecule-mediated RNA targeting: emerging strategies and therapeutic potential of RiboTAC
    Wei Zhou, 金锦梅, Ye Wu, 陈红专, Weidong Zhang, Xin Luan · 2026 · Targetome
  21. Discovery of Noninhibitory Macrocyclic Ligands for Protein Tyrosine Phosphatase 1B Using a Function-Based, Iterative Screening Strategy
    Jiajun Dong, Bo Li, Chung‐Wei Fu, Thomas J. Kodadek · 2026 · Journal of the American Chemical Society
  22. Selective Modulation of OTUB1 Noncanonical Function via a bioPhosTAC Strategy
    Seung Un Seo, Seon Min Woo, Minhyeong Choi, Soeun Rhee, Simmyung Yook, Donghyuk Shin, Kwang‐Su Park, Taeg Kyu Kwon · 2026 · Advanced Science
  23. General Strategy for Controlling Functional Lysine Acetylation via Induced Proximity
    Brianna Hill-Payne, Mohd Younis Bhat, George M. Burslem · 2026 · ACS Chemical Biology
  24. Chemically Induced Proximity in Biological Modulation
    Xiaokang Jin, Chen Zhou, Xiaoyu Zhang · 2026 · ACS Bio & Med Chem Au
  25. Rewriting Phosphorylation Codes: Toward Signal-State Editing with PhosTACs
    Dong-Ting Ke, Wei-Chen Chang, Yu-Yu Chen, Po‐Han Chen · 2026 · Kinases and Phosphatases
  26. Beyond PROTACs: Conditional Technologies and New Frontiers
    Ying Yang, Dongsheng Tang, Chunrong Yang · 2026 · Handbook of experimental pharmacology
  27. Nanoadaptor–driven targeted dephosphorylation of STAT3 for cancer immunotherapy
    Yinxi He, Ruihao Qian, Haohao Song, Hai Wang, Helin Feng, Ming Li · 2026 · Nano Today
  28. BindingDB Entry 50022782: Modulating Phosphorylation by Proximity-Inducing Modalities for Cancer Therapy.
    BindingDB · 2026 · UC San Diego
  29. BindingDB Entry 50020203: Exploitation of Proximity-Mediated Effects in Drug Discovery: An Update of Recent Research Highlights in Perturbing Pathogenic Proteins and Correlated Issues.
    BindingDB · 2024 · UC San Diego
  30. A BromoTag-Based Toolkit for Rapid Modulation of Chemically Induced Proximity
    Gianna M. Colombo, Kim DaWon, Muhammad Murtaza Hassan, Steven M. Corsello · 2026 · ACS Chemical Biology